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osting by EAbstract Ocular changes in genetically disabled children are great and of special importance. The
aim of the present study was to delineate the nature and frequency of ocular defects in genetically
disabled children. A cross sectional study was carried out. It included 95 genetically disabled
children who were chosen from the medical genetics and ophthalmic departments, Ain-Shams
University Hospitals, and examined for any associated ocular abnormalities. Studied patients were
divided into six groups (Group I: Chromosomal disorders (Down syndrome), Group II: Genetic
syndromes, Group III: Cranial anomalies, Group IV: Inborn errors of metabolism (IEM), Group
V: Cerebral palsy, Group VI: Mental retardation). Anomalies of the eyelids were detected in 63.1%
of our patients. They were signiﬁcantly increased in group I [Chromosomal disorders (Down syn-
drome)], compared to other groups. Errors of refraction were detected in all Down syndrome
patients.On the other hand some ocular ﬁndings were present in our Down syndrome patients
and not reported in the literature before; these include, lacrimal ﬁstula, lagophthalmos, heterochro-
mia, macrocornea and ectropion in 3.3% of patients, tortous retinal vessels, entropion, and prom-
inent upper punctum in 6.6%, ptosis in 10%, microcornea, absent foveal reﬂex, and
blepharophimosis in 13.3% of our cases. Lacrimal apparatus abnormalities were detected in
11.5% of our patients, the highest frequency was detected among the chromosomal disorder group
27%. Conjunctival and scleral abnormalities were also detected in 10.5% of our patients, where theTomanbay St., Hammamat,
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172 G.R. El-Hawary et al.group of chromosomal disorders had the highest frequency (20%). Cornea and anterior chamber
abnormalities were detected in 30.5%, these abnormalities had the same frequency (33%) in the
groups of chromosomal disorders, genetic syndromes and inborn errors of metabolism. Iris and
pupil abnormalities were detected in 15.7% of our patients. Lens abnormalities were detected in
10.5% of our patients, where the group of inborn errors of metabolism had the highest frequency
(44%). Ocular muscles and mobility abnormalities were diagnosed in 47.3% of our patients. Fun-
dus examination revealed abnormalities in 34.7% of patients,where the group of cerebral palsy had
the highest frequency (50%).Our results emphasize that, the earlier and better the visual sense func-
tion, the greater the chance the child will achieve his potential.The ophthalmologist, paediatricians,
geneticists must work hand in hand for detection of ocular disorders in genetically disabled children
to initiate diagnostic and therapeutic measures to control the disease.
 2011 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Handicap and disability are used as synonym but they aren’t [1].
The term ‘‘disabled people’’ as a political construction is widely
used by international organisations of disabled people, such as
Disabled Peoples’ International (DPI) [2]. Disability, according
to the World Health Organization [3], is deﬁned as ‘‘. . .an um-
brella term, covering impairments, activity limitations, and par-
ticipation restrictions’’. According to the adopted UN
Convention on the rights of persons with disabilities [4], persons
with disabilities include those who have long-term physical,
mental, intellectual or sensory impairments which, in interac-
tion with various barriers, may hinder their full and effective
participation in society on an equal basis with others [5].
Children may be considered to be handicapped, if, mentally
or physically, they lag behind their contemporaries, or if they
require special care, or if they have to make special adjust-
ments in educational, emotional or social spheres. Whatever
deﬁnition is used there will always be a number of borderline
cases [6]. Some people with disabilities do not like the term
‘‘handicap’’ because of a belief that it originally meant some-
one who could not work and went begging with their cap in
hand. This, appears to not be the true origin of the word.
However, the term ‘‘disabled people’’ is generally preferred
to ‘‘people with disabilities’’ [7].
In one survey, it was shown that 21.9% of cases of disabil-
ity resulted from prenatal damage; 3.0% arose from perinatal
factors; 29.0% were acquired during infancy and early child-
hood and 47.0% had no known cause [8].
The ﬁeld of genetics has important implications for people
with disability. Although only a limited number of national sur-
veys have been conducted to identify the etiological factors in
the development of disability, it is generally believed that 76%
of disability is caused by genetic factors [9]. Genetic causes of
disability may be due to chromosomal abnormalities which
can involve the loss, gain, or exchange of genetic material from
a chromosome pair. Such abnormalities often cause miscar-
riages, but may occasionally result in a baby with some kind
of disability as Down syndrome. Also disabilities may be caused
by speciﬁc genes that create damaging biomedical conditions
[10]. There are over 3000 different genetic causes of disability.
There are deﬁnite patterns of inheritance which govern whether
or not various traits affect us. The most prevalent genetic condi-
tions include Down syndrome, Klinefelter’s syndrome, Fragile
X syndrome, Neuroﬁbromatosis, congenital hypothyroidism,
Williams syndrome, Phenylketonuria (PKU), and Prader–Willi
syndrome. Other genetic conditions include Phelan–McDermidsyndrome (22q13del), Mowat–Wilson syndrome, genetic ciliop-
athy, and Siderius type X-linked mental retardation as caused
by mutations in the PHF8 gene [11].
The number of children and adolescents with disability is
signiﬁcant. Two hundred million children, meaning 10% of
the world’s youth, are born with a disability or become dis-
abled before the age of 18 [12]. The average percentage of peo-
ple with disabilities in Egypt is 10%, that means we have
around 7 million disabled people in Egypt, or 10% of the pop-
ulation. According to data available, more than 5% of chil-
dren have signiﬁcant disabilities. However accurate ﬁgures
are hard to come because families are reluctant to disclose
information about disabled members of their household.
‘‘Many Egyptian families hide their disabled children so that
even their neighbours are not aware of them’’ [13].
Eyes are the most precious gift of God – they act as our
window to the world. So it is important to take due care of
eyes during the development of the child. A visual impairment
occurs when any part of the optical system is defective, dis-
eased, or malfunctions. If the visual impairment is the result
of a defective part (or parts), it is usually present at birth (con-
genital). These include missing parts (e.g., absence of an iris;
absence of the eyes themselves), defective systems (e.g., dislo-
cation of the lens; holes in the retina; drainage systems that
are stopped up), and hereditary conditions (e.g., refractive er-
rors due to eyeballs that are too short or too long; improperly
shaped corneas; albinism) [14]. Diseases can be pre-natal (e.g.,
insult to the fetus in utero), at birth or post natal (e.g., damage
shortly thereafter), or adventitious (acquired later) (e.g., dis-
eases that develop gradually such as diabetes and some types
of retinal diseases). Malfunctions can be due to defective parts
or, secondarily, to body diseases such as rubella. There are
hundreds of eye problems (and combinations of problems) lo-
cated in the optical system itself. The eye specialist (ophthal-
mologist/optometrist) is qualiﬁed to identify or diagnose
these problems [15].
Ocular changes in genetically disabled children are great
and of special importance for the clinician during the diagnos-
tic process.
The objective of the present study is to delineate the nature
and frequency of ocular defects in genetically disabled children.2. Patients and methods
A cross sectional hospital based study was carried out through
a period of 2 years. The study included 95 genetically disabled
Table 1 Etiological classiﬁcation of genetically disabled
children.
Aetiology No. %
Genetic diseases
Group I: Chromosomal disorders (Down syndrome) 30 31.6
Group II: Genetic syndromes 21 22.1
Group III: Cranial anomalies 19 20.0
Group IV: Inborn errors of metabolism (IEM) 9 9.5
Group V: Cerebral palsy 10 10.5
Group VI: Mental retardation 6 6.3
Total 95 100
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and ophthalmic departments, Ain-Shams University Hospi-
tals, and examined for any associated ocular abnormalities.
The patients were 57 males and 38 females. Their age ranged
from 2 to 13 years (mean age 6.75 ± 3.26 years). For all the
patients, the following was done:
1. Detailed history including, age, sex, prenatal history: par-
ticulary in relation to maternal and paternal ages at time of
conception, maternal health, exposure to infections, terato-
genic drugs and radiation, complications of pregnancy as
toxaemia and bleeding, pregnancy loss (abortion or still
births), and neonatal death.
2. A three generation pedigree, with special attention to the
presence of similar cases in the family, birth order and,
consanguinity.
3. Thorough clinical examination including, complete exami-
nation of special organs of importance, detection of malfor-
mations and congenital anomalies anywhere in the body, in
addition to anthropometric studies to all patients were done.
4. Ophthalmologic examination including, visual acuity test-
ing, ocular motility and examination of the external eye
and anterior segment, cycloplegic refraction and fundus
examination to comment on. Iris was looked for colour, pat-
tern defect, and adhesions to the position, mobility, swell-
ings, lid margin, direction of palpebral ﬁssure and width.
Examination of the lacrimal system for lacrimal gland and
drainage system. Examination of the conjunctiva for dis-
charge, vascular engorgement, chemosis, mass, adhesions,
dryness and change of colour, nodules and pigmentations.
The cornea was examined by oblique illumination and by
slit lamp in indicated cases when it is possible, for diameter,
curvature, transparency, lustre, vascularity and irregularity
of the surface. Anterior chamber was examined by oblique
illumination and by slit lamp in indicated cases when it is
possible, for depth, clarity and abnormal contents of ante-
rior chamber. Lens was examined after dilatation of pupils
by slit lamp for any opacity (cataract) and for position (sub-
laxation, dislocation). Measurement of I.O.P. under general
anesthesia with Schiotz tonometer in suspected cases.
5. Radiological examination as plain X-ray of the skull, chest
and heart, and skeletal survey. Echocardiography, Ultraso-
nography (abdominal and ocular), brain C.T.0
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Figure 1 Etiological classiﬁcati6. Biochemical tests: which include, aminogram and qualita-
tive and quantitative detection of glycosaminoglycans.
7. Laboratory investigations: Complete blood picture, screen-
ing for STORCH infections and karyotype in suspected
chromosomal disorders.
8. Instrumental investigations: Audiometry when deafness
was expected. Electroencephalogram (E.E.G.) and Electro-
retinogram (E.R.G.).
3. Results
3.1. Studied patients were divided into six groups (Table 1 and
Fig. 1)
The highest frequency was found among the chromosomal dis-
order group, followed in descending order by genetic syn-
dromes, cranial anomalies, inborn errors of metabolism,
cerebral palsy and mental retardation. There was no signiﬁcant
difference as regards age, sex and parental consanguinity be-
tween the studied groups (P< 0.05) (Table 2).
3.2. As regards the maternal age at birth in all groups
It was observed that the group of mental retardation (group
VI) had the highest mean maternal age (42.83 ± 1.83 years),
and the group of cerebral palsy (group V) had the lowest meancerebral
palsy
Inborn error of
metabbolism  
Mental
retardation 
10.5%
9.5%
6.30%
on of handicapped children.
Table 2 Demographic characteristics of the examined patients, (95 patients).
Variable Group I
(30)
Group II
(21)
Group III
(19)
Group IV
(9)
Group V
(10)
Group VI
(6)
Total
No. % No. % No. % No. % No. % No. % No. %
Sex: Males 20 67 11 52 11 58 6 67 6 60 3 50 57 60.0
Positive family history 3 10 6 29 5 26 4 44 0 0 2 33 20 21.0
Positive consanguinity 11 37 6 29 4 21 4 44 3 30 4 67 32 33.6
Positive complications
during pregnancya
7 23 3 14 1 5 1 11 6 60 2 33 20 21.0
a Hypertension, bleeding and trauma.
174 G.R. El-Hawary et al.maternal age (28.90 ± 5.13). The highest mean paternal age
was observed in the group of mental retardation (group VI)
(42.83 ± 1.83 years), while the group of inborn errors of
metabolism had the lowest mean paternal age
(30.56 ± 7.49 years).
3.3. Ophthalmic examination of our patients (Tables 3–9)
3.3.1. Anomalies of the eyelids were detected in 60 of our
patients (63.1%)
They were signiﬁcantly increased (P< 0.05) in group I [chro-
mosomal group (Down syndrome)] compared to other groups
and 70% of Down patients had more than one eyelid anomaly.
3.3.2. As regards the lacrimal apparatus, 11 patients (11.5%)
had lacrimal apparatus abnormalities
The highest frequency was detected among the chromosomal
disorder group (8 patients, 27%), followed by the group of ge-
netic syndromes (P< 0.05).
3.3.3. Conjunctival and scleral abnormalities were presented in
10 of our patients (10.5%)
The group of chromosomal disorders had the highest fre-
quency (20%), followed by the group of genetic syndromes
(10%) (P< 0.05).
3.3.4. Cornea and anterior chamber abnormalities were detected
in 29 patients (30.5%)
The groups of chromosomal disorders, genetic syndromes and
inborn error of metabolism had the same frequency (33%), fol-
lowed by the group of cerebral palsy (30%). When each group
is compared with the other as regards these anomalies, it was
observed that the difference was statistically insigniﬁcant.
3.3.5. Iris and pupil abnormalities were found in 15 patients
(15.7%)
The highest frequency was detected among the group of chro-
mosomal disorders (8 patients, 27%) and the group of cranial
anomalies (5 cases, 26%).The difference between our groups
was statistically insigniﬁcant.
3.3.6. Lens abnormalities were noticed in 10 patients (10.5%)
Group IV of inborn error of metabolism had the highest fre-
quency (44%), followed by the group of genetic syndromes
(14%) and the difference between them was statistically signif-
icant (P< 0.05).3.3.7. Ocular muscles and mobility abnormalities were diagnosed
in 45 patients (47.3%)
The group of genetic syndromes and the group of cerebral
palsy had the highest frequency (62% and 50%) respectively
and the difference between the two groups was statistically
insigniﬁcant.
3.3.8. Fundus examination revealed abnormalities in 33 patients
(34.7%)
The group of cerebral palsy had the highest frequency (50%),
followed by the group of cranial anomalies (42%) and the dif-
ference between the two groups was statistically insigniﬁcant.
3.3.9. Errors of refraction were detected in 42 patients (44.2%)
They were signiﬁcantly increased in group I (chromosomal
group, 63%) compared to other groups. Twenty percent of
Down syndrome patients hadmore than one error of refraction.
4. Discussion
It can be difﬁcult to assess visual ﬁelds in young children or in
those whose development has been delayed, but this should be
attempted [16]. The eyes can yield many clues for diagnosis of
many genetic diseases, so as far as possible, every patient
should do full ophthalmologic examination [17].
The most obvious ophthalmologic observation on ﬁrst see-
ing the patient is that he or she is wearing thick spectacles.
Deterioration in vision accompanied by personality change,
intellectual deterioration or motor difﬁculties is very ominous
and requires urgent further investigation. In these circum-
stances, fundal examination and examination of eye move-
ments may reveal clues as to the aetiology of the disorder
[18]. Our ﬁndings in this study focused on ocular features of
genetically disabled children, they revealed that many genetic
diseases are associated with ocular manifestations, some of
them are obvious enough to be identiﬁed in any careful general
examination, others may require consultation of an ophthal-
mologist. Many of these signs are not speciﬁcally pathogno-
monic, but, even so, they can often help to differentiate [19].
Ophthalmological anomalies are common in children with
Down’s syndrome. In the present study, Down syndrome rep-
resents 31.6% of our cases. In our patients ophthalmologic
features were; upward slanting of palpebral ﬁssure in 76.6%
of cases, epicanthus of the eye lid in 26.6%, Brushﬁeld’s spots
in 23.3%, nasolacrimal duct obstruction in 16.6%, microcor-
nea, blepharophimosis and absent foveal reﬂex were detected
in 13.3%, ptosis, chronic conjunctivitis and hypoplastic optic
Table 3 Ocular and visual defects among genetically disabled children.
Eye problems Group I Group II Group III Group IV Group V Group VI Total %
No. % No. % No. % No. % No. % No. % No. %
Eye lid abnormalities
positive
28 93 11 52 7 37 4 44 6 60 4 67 60 63.1
Lacrimal apparatus abnormalities
positive
8 27 3 14 0 0 0 0 0 0 0 0 11 11.5
Conjunctival and scleral abnormalities
positive
6 20 2 10 1 5 0 0 0 0 1 17 10 10.5
Cornea and anterior chamber abnormalities
positive
10 33 7 33 5 26 3 33 3 30 1 17 29 30.5
Iris and pupil abnormalities
positive
8 27 1 5 5 26 1 11 0 0 0 0 15 15.7
Lens abnormalities
positive
3 10 3 14 0 0 4 44 0 0 0 0 10 10.5
Ocular muscles and mobility abnormalities
positive
13 43 13 62 9 47 4 44 5 50 1 17 45 47.3
Fundus abnormalities
positive
10 33 7 33 8 42 2 22 5 50 1 17 33 34.7
Errors of refraction
positive
19 63 10 48 7 37 2 22 3 30 1 17 42 44.2
Ocular features in Egyptian genetically disabled children 175disc were found in 10%, while entropion, congenital cataract,
and hypopigmented fundus were detected in 6.6%, errors of
refraction were detected in all of our patients (100%) as myo-
pia in 36.7%, astigmatism in 33.3% and hypermetropia in
30% of cases. These ﬁndings were closely related to that re-
ported previously in patients with Down syndrome [20–24].
Unlike previous reports [25–28] no congenital glaucoma,
blepharitis, amblyopia, epiblepharon, keratoconus, and gangli-
onic neuroretinal hypoplasia were detected in Egyptian Down
syndrome patients. On the other hand some ocular ﬁndings
were present in our patients and to our knowledge not re-
ported in the literature. These include, lacrimal ﬁstula, lagoph-
thalmos, heterochromia, macrocornea and ectropion in 3.3%
of patients, tortous retinal vessels, entropion, and prominent
upper punctum in 6.6%, ptosis in 10%, microcornea, absent
foveal reﬂex, and blepharophimosis in 13.3% of cases. Creavin
and Brown [29] performed a comprehensive review of the
available literature to determine the common ophthalmic dis-
orders in children aged 0–16 years with Down syndrome. They
found that refractive errors was a common ﬁnding particulary
hyperopia. Strabismus was also reported particulary esodevia-
tion. Other frequent ﬁndings include poor visual acuity, nys-
tagmus and blepharitis, whereas cataract and glaucoma were
less common but had potentially serious implications for
future vision. The UK Down’s Syndrome Medical Interest
group (DSMIG) guidelines for ophthalmic screening were lo-
cally implemented a protocol that include neonatal eye exam-
ination by an ophthalmologist and a comprehensive
ophthalmological examination (cycloplegic refraction, oph-
thalmoscopy, and orthoptic assessment) by at least the age
of 3 years. This will be anticipated to improve developmental
and functional outcome in Down syndrome [30]. Some authors
argue that the characteristic traits of Down’s syndrome result
from a combination of gene dosage effects as a result of extra
copies of genes on chromosome 21 [31]. Variability in the ocu-
lar features of Down’s syndrome could relate to polymorphism
in these genes [32].
Others believe that the extra chromosomal material causes a
generalized disruption in the genetic balance of cells. From thisviewpoint non-speciﬁc developmental instability following
aneuploidy accounts for ocular anomalies in Down’s syndrome.
Rubinstein–Taybi syndrome represented 19% of patients of
group II in our study. The most common ocular ﬁndings de-
tected among these patients include, antimongoloid slant and
hypertelorism in 75%, long eye lashes in 50%, epicanthus,
astigmatism, macrocornea and glaucoma were observed in
25%, while more than one ocular anomaly was detected in
100% of cases. Our ﬁndings were nearly similar to what was
previously reported that the main features that allow for diag-
nosis of Rubinstein–Taybi syndrome are congenital or juvenile
glaucoma, ptosis of eyelids and refractive errors [33]. Unlike to
what reported by van Genderen et al. [34], no nasolacrimal
duct problems, cataract, coloboma, nystagmus, corneal and
retinal abnormalities were detected in our patients. Quaranta
and Quaranta [35], emphasized the importance of detailed,
complete ocular examinations in patients with Rubinstein–
Taybi syndrome, and also highlights that ocular abnormalities
are rarely associated with this disease.
Crouzen syndrome is an autosomal dominant disorder with
complete penetrance and variable expressivity. Gene locus has
been mapped to chromosome 10q26 [36]. It is characterized by
premature closure of calvarial and cranial base sutures as well
as those of the orbit and maxillary complex (craniosynostosis)
[37]. This disorder, accounts for approximately 4.5% of all
cases of craniosynostosis [38]. In our study Crouzen syndrome
represented 19% of patients of group II. The most common
ocular ﬁndings in our cases were hypertelorism, which was
present in all patients, followed by divergent squint and prop-
tosis which were found in 50% of cases. Optic atrophy, papil-
loedema, antimongoloid slant were diagnosed in 25% of cases.
These ﬁndings were similar to what reported by Ernest and
Fernando [39]. Additionally, Hoefkens et al. [40] reported that,
nystagmus, iris coloboma, aniridia, anisocoria, microcornea,
megalocornea, cataract, ectopia lentis, blue sclera, glaucoma,
luxation of the eye globes rarely occur among patients with
Crouzen syndrome.
Hallermann–Streiff syndrome is a rare syndrome, which in-
volves multiple congenital abnormalities affecting chieﬂy the
Table 4 Ocular signs detected among patients with Down
syndromes (30/95 – 31.6%).
Variable No. %
Eye lid
Upward slanting 23 76.6
Epicanthus 8 26.6
Blepharophimosis 4 13.3
Ectropion 1 3.3
Ptosis 3 10.0
Entropion 2 6.6
More than one anomaly 21 70.0
Lacrimal apparatus
Lagophthalmos 1 3.3
N.L.D.a obstruction 5 16.6
Lacrimal ﬁstula 1 3.3
Prominent upper punctum 2 6.6
Conjunctiva
Chronic conjunctivitis 3 10.0
Cornea and anterior chamber
Corneal opacity 2 6.6
Macrocornea 1 3.3
Microcornea 4 13.3
Iris
Heterochromia 1 3.3
Brushﬁeld’s spot 7 23.3
Lens
Congenital cataract 2 6.6
Ocular motility
Nystagmus 9 30.0
Alt. convergent squint 1 3.3
Unilateral convergence 2 6.6
Fundus
Absent foveal reﬂex 4 13.3
Hypoplastic optic disc 3 10.0
Tortous retinal vessels 2 6.6
Hypopigmented fundus 2 6.6
Errors of refraction
Myopia 11 36.7
Hypermetropia 9 30.0
Astigmatism 10 33.3
More than one anomaly 6 20.0
a Naso lacrimal duct.
176 G.R. El-Hawary et al.head and face. Virtually all cases are sporadic and thus there is
no obvious pattern of inheritance. The most likely hypothesis
is that of a single mutant gene (dominant) with most cases rep-
resenting fresh mutations. A defect of elastin and abnormal
glycoprotein metabolism has been reported [41]. This syn-
drome was found in two cases of our patients and it accounts
for 9.5% of cases of group II, the most common ocular fea-
tures detected were nystagmus, cataract and microphthalmia
in all patients (100%), followed by antimongoloids slanting,
blepharophimosis and divergent squint in 50% of cases. These
ﬁndings come in agreement with other authors [42,43]. Myung
et al. [44] experienced a case of Hallermann–Streiff syndrome
in a 6 year old female with bilateral microphthalmia and con-
genital cataract. She also showed pinhole pupil, strabismus
and aphakia, which is considered a rare ocular sign in Haller-mann–Streiff syndrome. Other ocular ﬁndings that were re-
ported [45] in Hallermann–Streiff syndrome but not found in
our study include, blue sclera, posterior synechia, aphakia,
and secondary glaucoma.
Bardet–Biedle syndrome is a multi-system autosomal reces-
sive disorder [46]. In our study it represented 23.8% of patients
of group II, retinitis pigmentosa was the commonest ocular
sign detected among 80% of our patients. Other ocular ﬁnd-
ings detected in our patients include, nystagmus in 60%, pale
optic disc and hypermetropia in 40%, bilateral persistent hya-
loid system, attenuated retinal blood vessels and astigmatism
in 20%. Nearly, similar ﬁndings were previously reported
[47–49]. However unlike to what was previously reported by
Hrynchak [50] glaucoma and cataract were not detected
among our patients. On the other hand and to our knowledge,
bilateral persistent hyaloids system which was found in one of
our patients was not previously reported.
Noonan syndrome is a clinically heterogeneous condition.
Genetic investigations have identiﬁed mutations in several
genes. It is estimated that these mutations can explain approx-
imately 60% of patients with Noonan syndrome [51]. In our
study Noonan syndrome was detected in 4.7% of patients of
group II. Ocular ﬁndings of our patient include, blepharophi-
mosis, microphthalmia, alternating divergent squint and con-
genital cataract. Shaw et al. [52] reported that the
characteristic facial features of Noonan syndrome include
hypertelorism (74%), epicanthal folds (39%), down-slanting
palpebral ﬁssures (38%), ptosis (48%), strabismus (48%),
refractive errors (61%), amblyopia (33%), nystagmus (9%),
cataracts, uveitis and retinal ﬁndings (20%), as well as less
common ﬁndings of optic disc hypoplasia, coloboma, and ker-
atoconus. Ptosis associated with Noonan syndrome has been
described by many authors [53,54]. Most of the previous ﬁnd-
ings were not reported in our patients.
Robinow syndrome is a severe skeletal malformation syn-
drome that also affects other organs and has characteristic fa-
cial features which, include macrocephaly, broad prominent
forehead, ocular hypertelorism, prominent eyes and midface
hypoplasia [55]. Robinow syndrome is rare syndrome [56]. It
was described in 4.7% among our patients of group II. Ocular
signs observed in our patient were, hypertelorism, antimongol-
oid slanting of palpebral ﬁssure and macrocornea. Many
authors described similar ocular ﬁndings [57–59].
Prader–Willi syndrome is the result of missing or abnormal
genetic material on the paternally contributed chromosome 15
[60]. In people of all ethnic backgrounds Prader–Willi syn-
drome is usually diagnosed by the appearance and behaviors
of a child, then conﬁrmed by specialized genetic testing of a
blood sample [61]. In our study Prader–Willi syndrome was
diagnosed in one patient (4.7%), his ocular manifestations in-
clude upward slant, partial synophrys and alternating diver-
gent squint. Libov and Maino [62] reported other ocular
ﬁndings for patients with Prader–Willi syndrome which in-
clude iris hypopigmentation with depressed visual acuity, mod-
erate to high refractive errors, strabismus, cataracts, congenital
ocular ﬁbrosis syndrome, diabetic retinopathy, and congenital
ectropion uveal. The numerous ocular, systemic, and func-
tional abnormalities of patients with Prader–Willi syndrome
make it mandatory that all patients should routinely receive
primary optometric vision care.
Neuroﬁbromatosis (NF) is a collective name for a group of
three genetically distinct but related disorders in which benign
Table 5 Ocular manifestations in the group of genetic syndromes (21/95 – 22.1%).
Syndrome Eye problems No. %
Rubinstein–Taybi 4 19.0
Antimongoloid slanting 3 75.0
Hypertelorism 3 75.0
Long eyelashes 2 50.0
Epicanthus 1 25.0
Hypermetropia 2 50.0
Astigmatism 1 25.0
Macrocornea 1 25.0
Glaucoma 1 25.0
More than one anomaly 4 100.0
Bardet–Biedle syndrome 5 23.8
Retinitis pigmentosa 4 80.0
Bilateral persistent hyaloids system 1 20.0
Attenuated retinal B.V. 1 20.0
Pale optic disc 2 40.0
Nystagmus 3 60.0
Divergent squint 1 20.0
Hypermetropia 2 40.0
Astigmatism 1 20.0
More than one anomaly 5 100.0
Neuroﬁbromatosis 1 4.7
Lid neuroma 1 100.0
Ptosis 1 100.0
Proptosis 1 100.0
More than one anomaly 1 100.0
Hallermann–Streiﬀ 2 9.5
Antimongoloid slanting 1 50.0
Microphthalmia 2 100.0
Nystagmus 2 100.0
Cataract 2 100.0
Blepharophimosis 1 50.0
Divergent squint 1 50.0
Robinow syndrome 1 4.7
Hypertelorism 1 100.0
Antimongoloid slanting 1 100.0
Macrocornea 1 100.0
More than one anomaly 1 100.0
Prader–Willi syndrome 1 4.7
Upward slant 1 100.0
Partial synophrys 1 100.0
Alternating divergent squint 1 100.0
Noonan syndrome 1 4.7
Blepharophimosis 1 100.0
Microphthalmia 1 100.0
Alternating divergent squint 1 100.0
Congenital cataract 1 100.0
More than one anomaly 1 100.0
Crouzen syndrome 4 19.0
Hypertelorism 4 100.0
Proptosis 2 50.0
Divergent squint 2 50.0
Optic atrophy 1 25.0
Papilloedema 1 25.0
Antimongoloid slanting 1 25.0
More than one anomaly 4 100.0
Sturge–Weber syndrome 2 9.5
Lid-haemangioma 2 100.0
Glaucoma 2 100.0
Nystagmus 2 100.0
More than one anomaly 2 100.0
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Table 8 Ocular signs detected among patients with inborn
errors of metabolism (9/95 – 9.5%).
Aetiology No. %
Galactosemia 4 44.4
Cataract 4 44.4
Nystagmus 2 22.2
Blepharophimosis 1 11.1
Microphthalmia 1 11.1
More than one anomaly 3 33.3
Mucopolysaccharidosis 5 55.5
Puﬃness of eyelids 3 33.3
Cloudy cornea 4 44.4
Nystagmus 1 11.1
Optic atrophy 1 11.1
More than one anomaly 4 44.4
Table 9 Ocular signs among the mental retardation group (6/
95 – 6.3%).
Anomaly No. %
Antimongoloid slanting 1 16.6
Blepharophimosis 1 16.6
Greyish discolouration of eyelashes 1 16.6
Long eyelashes 1 16.6
Alternating convergent squint 2 33.3
Congenital tortous vessels 1 16.6
More than one anomaly 0 0
Table 6 Ocular signs detected among patients with cranial
anomalies (19/95 – 20%).
Aetiology No. %
Osteopetrosis 2 10.5
Macrocornea 1 5.2
Pin-pointed pupil 1 5.2
Nystagmus 2 10.5
Optic atrophy 1 5.2
Papilloedema 1 5.2
More than one anomaly 2 10.5
Microcephaly 5 26.3
Alternating divergent squint 2 10.5
Hypermetropia 1 5.2
Astigmatism 2 10.5
Myopia 2 10.5
More than one anomaly 3 15.7
Congenital hydrocephalus 10 52.6
Blepharophimosis 1 5.2
Microcornea 1 5.2
Antimongoloid slanting 1 5.2
Upward slanting 2 10.5
Sun set appearance 7 36.8
Papilloedema 4 21.0
Optic atrophy 6 31.5
More than one anomaly 8 42.1
Craniosynostosis 2 10.5
Macrocornea 1 5.2
Optic atrophy 2 10.5
Strabismus 1 5.2
More than one anomaly 2 10.5
Table 7 Ocular signs among patients with cerebral palsy (10/
95 – 10.5%).
Anomaly No. %
Antimongoloid slanting 2 20.0
Epicanthus 2 20.0
Errors of refraction 2 20.0
Hypertelorism 1 10.0
Macrocornea 2 20.0
Nystagmus 1 10.0
Bilateral alternating convergent squint 2 20.0
Apparent convergent squint 2 20.0
Abnormal retinal pigmentation 2 20.0
Tortous retinal vessels 2 20.0
Wide optic pit 1 10.0
Absent foveal reﬂex 1 10.0
More than one anomaly 8 80.0
178 G.R. El-Hawary et al.(non-cancerous) growths or tumours affect the nervous sys-
tems. They are neuroﬁbromatosis 1 – or peripheral neuroﬁbro-
matosis, neuroﬁbromatosis 2 – or central neuroﬁbromatosis
and schwannomatosis which is a rare type that produces multi-
ple benign tumors in the Schwann cells of peripheral nerves
[63]. One case of neuroﬁbromatosis (NF1) was included in
our study representing 4.7% of patients of group II. Lid neu-
roma, ptosis and proptosis were observed in this patient. Many
literature [64,65] reported similar ocular signs of NF1. Unlike
to what was reported by Destro et al., [66] iris (Lisch) nodules,
congenital glaucoma, plexiform neuroﬁbromas of the eyelids,uveal hamartomas, and retinal lesions were not detected in
our patient.
Sturge–Weber syndrome (SWS) belongs to a group of dis-
orders collectively known as the phakomatoses (‘‘mother-
spot’’ diseases). It consists of congenital hamartomatous mal-
formations that may affect the eye, skin, and CNS at different
times [67]. It was diagnosed in two cases of our patients
(9.5%), ocular ﬁndings include lid-haemangioma, glaucoma
and nystagmus. Cheng [68] reported closely similar ﬁndings.
Ocular signs detected among our patients with cranial
anomalies differ according to the type of anomaly. Osteopetro-
sis has been diagnosed in 10.5% of our study group. They rep-
resented ophthalmologically with macrocornea in 5.2%, optic
atrophy in 5.2%, papilloedema in 5.2%, nystagmus in 10.5%,
pin pointed pupils in 5.2%. Many studies are in agreement
with our ﬁndings [69,70]. On the other hand, exophthalmos
and impaired extraocular muscle function which were, previ-
ously reported [71] as ocular signs of osteopetrosis were not
observed in our patients.
Craniosynostosis was diagnosed in 10.5% of our patients.
The ocular manifestation recorded were, macrocornea in
5.2%, optic atrophy in 10.5%, strabismus in 5.2%. Baranello
et al. [72] reported similar ocular ﬁndings. However, in a retro-
spective review by Khan et al. [73] of 141 cases of syndromic
craniosynostosis 40.3% of patients had astigmatism, anisome-
tropia was detected in 18%, horizontal strabismus was found
in 70% (38% exotropia, 32% esotropia), 39.8% of their pa-
tients had visual acuity of 6/12 or worse in their better eye,
which means that refractive errors are common. On the other
hand, macrocornea which was observed in our patients was
not mentioned before. The ocular aspects of craniosynostosis
Ocular features in Egyptian genetically disabled children 179may be considered in terms of detection and prevention of vi-
sual loss, ocular motility problems, binocular vision, lacrimal
duct problems and miscellaneous ocular problems [74].
Microcephaly is deﬁned as a head circumference >3 stan-
dard deviations below mean for age and gender. It is a sign
of a small brain (micrencephaly), and affected children usually
have some degree of neurologic impairment [75]. It was diag-
nosed in 26.3% of our patients of group III, ocular manifesta-
tions include, alternating divergent squint in 10.5%,
hypermetropia in 5.2%, astigmatism in 10.5%, myopia
in10.5%, while more than one anomaly was detected in
15.7%. Similar ﬁndings were previously reported [76].
Congenital hydrocephalus is caused by a complex interac-
tion of genetic and environment factors. Aqueductal stenosis
(narrowing) is the most frequent cause. Blockage of fourth
ventricle outlet (Dandy–Walker syndrome) or Chiari malfor-
mations (in association with Spina Biﬁda) are other common
causes [77]. Congenital hydrocephalus was diagnosed in 10
cases (52.6%) of our patients of group III, ocular manifesta-
tion detected were blepharophimosis, microcornea and anti-
mongoloid slant of palpebral ﬁssure in 5.2% of patients,
upward slant in 10.5%, sunset appearance in 36.8%, papilloe-
dema in 21%, optic atrophy in 31.5% and more than one
anomaly was detected in 42.1%. Some reports are in agree-
ment to our results [78,79]. However, microcornea, antimon-
goloid slant and upward slant of palpebral ﬁssure reported
in our study were not mentioned before.
Cerebral palsy was diagnosed in 10.5% of our patients. In
our study ocular signs include, antimongoloid slanting, epican-
thus, errors of refraction, macrocornea, abnormal retinal pig-
mentation and tortous retinal vessels, each in 20% of cases.
Nystagmus, foveal reﬂex, and wide optic pit in 10% of our pa-
tients, while strabismus was detected in 40%. A series of arti-
cles mentioned closely similar ﬁndings [80–84]. On the other
hand, wide optic pit, which was detected in our patients, was
not mentioned before.
Our study also comprised four cases of galactosemia, repre-
senting (44.5%) of patients in group IV. Cataract was noticed
in 44.4% of patients, while nystagmus, blepharophimosis and
microphthalmia were less frequent (22.2%). As regards cata-
ract our results are nearly similar to what was reported previ-
ously [85,86]. Cuthbert et al. [87] mentioned that cataracts was
reported in 30% of 314 individuals with galactosemia. On the
other hand Hadeel et al. [88], reported a case of classic galac-
tosemia that presented with a rare ocular ﬁnding, Peters’
anomaly.
Hurler syndrome is a type of mucopolysaccharidosis called
MPS I. It is the most severe type and it is categorized as MPS I
H [89]. It has been diagnosed in ﬁve cases in our study, repre-
senting (55.5%) of group IV. Puffy eyelids was observed in
33.3% of cases, cloudy cornea in 44.4% of patients, while nys-
tagmus and optic atrophy were noticed in 11.1% of the cases.
In another Egyptian study, Shawky et al. [90] reported corneal
clouding and early optic atrophy in 5.6% of patients with MPS
type I. Other authors [91,92] reported that ocular manifesta-
tions of Hurler syndrome include, corneal clouding, pigmen-
tary retinopathy, optic atrophy and glaucoma. In patients
with MPS ophthalmological examination, including slit-lamp,
fundus examination and regular measurement of the intraocu-
lar pressure, are necessary for the early detection and manage-
ment of potential complications.Mental retardation is a condition diagnosed before the age
of 18 years that includes below-average general intellectual
function, and a lack of the skills necessary for daily living.
Mental retardation (MR) affects about 1–3% of the popula-
tion [93]. Defects that may lead to mental retardation involve
a lesion or lesions in the central nervous system (CNS) of di-
verse etiology, including genetic, nutritional, infectious, toxic
and traumatic brain disorders [94]. The prevalence of visual
and ocular disorders in children with MR is high, and can
inﬂuence sensory-motor development and learning ability
[95]. It constitutes a major problem in Egypt because it affects
the quality of life of persons and the welfare of their families.
Temtamy et al. [96] reported that the prevalence of mental
retardation was 3.9% among an Egyptian population in Assuit
Governorate. Although, we could not determine the direct eti-
ology of mental retardation in 6.3% of cases in this study. We
studied the most appropriate pre and post-natal abnormalities
and associated developmental major signs in all cases for prob-
able further evaluation. Ocular manifestation detected among
them were, antimongoloid slanting, blepharophimosis, greyish
discolouration of eye lashes, long eye lashes and congenital
tortous retinal vessels in (16.6%) of cases, while alternating
convergent squint was detected in 33.3% of the patients. The
prevalence of strabismus among individuals with mental retar-
dation was more than that reported in various studies in differ-
ent populations which have shown a prevalence of 1–5% for
strabismus in the general population [97].5. Conclusion
On the whole, the most effective way to combat genetic disor-
ders is through medical research. Currently, research in the
molecular and cell biology of the eye holds promise for more
effective management of heritable eye disorders and provides
hope for therapy and, ultimately, cure for some genetic
disorders.
As vision is the most important sense for general develop-
ment and education. The earlier and better the visual sense
function, the greater the chance the child has achieved his po-
tential. The ophthalmologist, paediatricians, geneticists must
work hand in hand for detection of ocular disorders in genet-
ically disabled children to initiate diagnostic and therapeutic
measures to control the disease. The results also emphasize
the need for establishing an efﬁcient system to provide regular
ophthalmic care for genetically disable children.References
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